Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 1, 2011, Pages 45-51

  Liu, Taotao ^a   Xue, Ruyi ^a   Dong, Ling ^a   Wu, Hao ^a   Zhang, Danying ^a   Shen, Xizhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

antibody microarray; biomarkers; cytokines; hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; CYTOKINE; HEPATITIS B ANTIBODY; TUMOR MARKER;

ARTICLE; BLOOD; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PROTEIN MICROARRAY;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CYTOKINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS;

EID: 78650746601     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq111     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55: 74-108.
2. Parkin DM. International variation. Oncogene 2004, 23: 6329-6340.
3. Chan D and Sell S. Tumor markers. In: Burtis CA and Ashwood A (eds). Tietz Textbook of Clinical Chemistry, 3rd edn. Philadelphia: Saunders, 1999, 722-749.
4. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P and Domenicali M, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001, 34: 570-575.
5. Perz JF, Armstrong GL, Farrington LA, Hutin YJF and Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45: 529-538.
6. Lopez JB. Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev 2005, 26: 65-79.
7. Haab BB. Antibody arrays in cancer research. Mol Cell Proteomics 2005, 4: 377-383.
8. Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem 2006, 52: 1651-1659.
9. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D and Mehra R, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005, 353: 1224-1235.
10. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C and Huang RP. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004, 109: 507-515.
11. Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB and Cordon-Cardo C. Profiling bladder cancer using targeted antibody arrays. Am J Pathol 2006, 168: 93-103.
12. Haab BB, Dunham MJ and Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2001, 2: Research0004.
13. Mantovani A, Gray PA, Damme JV and Sozzani S. Macrophage-derived chemokine (MDC). J Leukoc Biol 2000, 68: 400-404.
14. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W and Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005, 60: 685-688.
15. Nakanishi T, Imaizumi K, Hasegawa Y, Kawabe T, Hashimoto N, Okamoto M and Shimokata K. Expression of macrophage-derived chemo-kine (MDC)/CCL22 in human lung cancer. Cancer Immunol Immunother 2006, 55: 1320-1329.
16. Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E and Homann HE. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther 2002, 9: 793-803.
17. Yoshimura T, Yuhki N, Wang MH, Skeel A and Leonard EJ. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP,MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 1993, 268: 15461-15648.
18. Bezerra JA, Witte DP, Aronow BJ and Degen SJ. Hepatocytospecific expression of the mouse hepatocyte growth factor-like protein. Hepatology 1993, 18: 394-399.
19. Danilkovitch-Miagkova A and Leonard EJ. Anti-apoptotic action of macrophage stimulating protein (MSP). Apoptosis 2001, 6: 183-190.
20. Wang M, Wang D and Chen Y. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyro-sine kinase. Carcinogenesis 2003, 23: 1291-1300.
21. Camp ER, Yang A, Gray MJ, Fan F, Hamilton SR, Evans DB and Hooper AT, et al. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target. Cancer 2007, 109: 1030-1039.
22. Chen YQ, Zhou YQ, Angeloni D, Kurtz AL, Qiang XZ and Wang MH. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines. Exp Cell Res 2000, 261: 229-238.
23. Rampino T, Gregorini M, Soccio G, Maggio M, Rosso R, Malvezzi P and Collesi C, et al. The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. Am J Surg Pathol 2003, 27: 279-285.
24. Zhu M and Paddock GV. Expression of the hepatocyte growth factor-like protein gene in human hepatocellular carcinoma and interleukin-6-induced increased expression in hepatoma cells. Biochim Biophys Acta 1999, 1449: 63-72.